首页> 外文OA文献 >Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study

【2h】

Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study

机译：伊立替康和奥沙利铂对转移性结直肠癌患者总生存的影响：一项基于人群的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

A look at the temporal impact of advancements in therapeutic options in the last 10 years—from fluorouracil to irinotecan and oxaliplatin—on overall survival in a population-based cohort.

机译：回顾过去10年中从氟尿嘧啶到伊立替康和奥沙利铂治疗选择的进展对基于人群的总体生存的时间影响。

著录项

作者
Lim, Howard J.; Gill, Sharlene; Speers, Caroline; Melosky, Barbara; Barnett, Jeff; Fitzgerald, Catherine; O'Reilly, Susan; Kennecke, Hagen;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. CMAB009联合伊立替康或伊立替康单药二线治疗氟嘧啶和奥沙利铂治疗失败的KRAS野生型转移性结直肠癌患者的研究:一项前瞻性、开放、随机、Ⅲ期试验 [J] . 石远凯, 白丽, 张沂平, 癌症（英文版） . 2020,第007期
2. Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study [J] . Howard J. Lim, Sharlene Gill, Caroline Speers, Journal of Oncology Practice . 2009,第4期

机译：伊立替康和奥沙利铂对转移性结直肠癌患者总生存的影响：一项基于人群的研究
3. Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study [J] . Norbert Marschner, Dirk Arnold, Erik Engel, Clinical Epidemiology . 2015,第1期

机译：与基于伊立替康的一线治疗相比，基于奥沙利铂的一线化疗可改善转移性结直肠癌患者的总生存率–前瞻性队列研究结果
4. Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G) [J] . Sakai Daisuke, Taniguchi Hiroya, Sugimoto Naotoshi, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第1期

机译：Panitumumab Plus in Irinotecan与氟丙二屈氏蛋白酶酸难以氟嘧啶，Irinotecan和Oxaliplatin（Wjog 6510g）患者的随机素in inerucotecan对伊喹仑（Cetuximab）对氨基替康酸的氨管
5. Computed Tomography Image-Based Deep Survival Regression for Metastatic Colorectal Cancer Using a Non-proportional Hazards Model [C] . Alexander Katzmann, Alexander Muehlberg, Michael Suehling, International Workshop on Predictive Intelligence In MEdicine;International Conference on Medical Image Computing and Computer Assisted Intervention . 2019

机译：基于非比例风险模型的基于层析成像的深度生存回归分析用于转移性结直肠癌的研究
6. Use and outcomes of newer chemotherapeutic agents in colorectal cancer patients using Irinotecan as a case study. [D] . Obeidat, Nour A. 2008

机译：以伊立替康为例的结直肠癌患者中新型化疗药物的使用和结果。
7. Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study [O] . Howard J. Lim, Sharlene Gill, Caroline Speers, 2009

机译：伊立替康和奥沙利铂对转移性结直肠癌患者总生存的影响：一项基于人群的研究
8. Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer : NORDIC 9 [O] . Winther, Stine Braendegaard, Österlund, Pia, Berglund, Åke, 2017

机译：随机研究比较了全剂量单药治疗（S-1，然后伊立替康）和减剂量联合治疗（S-1 /奥沙利铂，然后S-1 /伊立替康）作为老年转移性大肠癌患者的初始治疗的方法：NORDIC 9

Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study

摘要

著录项

相似文献

相关主题

期刊订阅